Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma

Background : Several blood conservation strategies have been tried with the purpose of reducing homologons blood transfusion. Patients & Methods : In a prospective randomized study, the potential benefits of acute normovolemic hemodilution (ANH) with autologous transfusion were investigated as...

Full description

Bibliographic Details
Main Authors: Imtiaz A Naqash, M A Draboo, Abdul Qayoom Lone, Showkat H Nengroo, Altaf Kirmani, Abdul Rashid Bhat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2011;volume=27;issue=1;spage=54;epage=58;aulast=Naqash
_version_ 1818367069613195264
author Imtiaz A Naqash
M A Draboo
Abdul Qayoom Lone
Showkat H Nengroo
Altaf Kirmani
Abdul Rashid Bhat
author_facet Imtiaz A Naqash
M A Draboo
Abdul Qayoom Lone
Showkat H Nengroo
Altaf Kirmani
Abdul Rashid Bhat
author_sort Imtiaz A Naqash
collection DOAJ
description Background : Several blood conservation strategies have been tried with the purpose of reducing homologons blood transfusion. Patients & Methods : In a prospective randomized study, the potential benefits of acute normovolemic hemodilution (ANH) with autologous transfusion were investigated as a blood conservation technique in surgical excision of intracranial meningioma. Over a period of 2 years, 40 patients undergoing excision of intracranial meningioma were randomly assigned to two groups of 20 patients each. Group I (Control Group) received conventional homologous blood intraoperatively and were not subjected to ANH. In Group II (ANH Group), Acute Normovolemic Hemodilution was initiated to a target hematocrit of 30% after induction of anesthesia. Parameters studied included changes in hemoglobin, hematocrit and hemodynamic parameters. Results : The mean value of blood withdrawn in ANH group was 802.5 ± 208 ml. This was replaced simultaneously with an equal volume of 6% Hydroxyethyl starch to maintain normovolemia. There was no statistically significant variation in mean hemoglobin levels between the two groups at various stages of study. Hematocrit decreased significantly in both the groups at various stages as compared to preoperative values , the decrease being more but insignificant in group II. Changes in heart rate and mean blood pressure were similar and without statistically significant differences in either group at various stages of study. The amount of surgical blood loss in group I was 835.29 ± 684.37 ml, as compared to 865 + 409.78 ml in group II. The difference was statistically insignificant (p>0.05). The mean volume of homologous blood transfused in group I was 864.71 ± 349.89 ml, as compared to 165 ± 299.6 ml in group II which was statistically significant (p<0.05). In group II (ANH Group) only 5 patients (25%) required homologous blood whereas in group I I all patients (100%) needed homologous blood. Conclusion : We conclude that acute normovolemic hemodilution up to a target hematocrit of 30% is safe and effective in reducing the need for homologous blood in neurosurgical patients undergoing excision of intracranial meningioma.
first_indexed 2024-12-13T22:46:12Z
format Article
id doaj.art-1715974b8bff4ee5b7c59c4d9b88ea6a
institution Directory Open Access Journal
issn 0970-9185
language English
last_indexed 2024-12-13T22:46:12Z
publishDate 2011-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Anaesthesiology Clinical Pharmacology
spelling doaj.art-1715974b8bff4ee5b7c59c4d9b88ea6a2022-12-21T23:28:43ZengWolters Kluwer Medknow PublicationsJournal of Anaesthesiology Clinical Pharmacology0970-91852011-01-012715458Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningiomaImtiaz A NaqashM A DrabooAbdul Qayoom LoneShowkat H NengrooAltaf KirmaniAbdul Rashid BhatBackground : Several blood conservation strategies have been tried with the purpose of reducing homologons blood transfusion. Patients & Methods : In a prospective randomized study, the potential benefits of acute normovolemic hemodilution (ANH) with autologous transfusion were investigated as a blood conservation technique in surgical excision of intracranial meningioma. Over a period of 2 years, 40 patients undergoing excision of intracranial meningioma were randomly assigned to two groups of 20 patients each. Group I (Control Group) received conventional homologous blood intraoperatively and were not subjected to ANH. In Group II (ANH Group), Acute Normovolemic Hemodilution was initiated to a target hematocrit of 30% after induction of anesthesia. Parameters studied included changes in hemoglobin, hematocrit and hemodynamic parameters. Results : The mean value of blood withdrawn in ANH group was 802.5 ± 208 ml. This was replaced simultaneously with an equal volume of 6% Hydroxyethyl starch to maintain normovolemia. There was no statistically significant variation in mean hemoglobin levels between the two groups at various stages of study. Hematocrit decreased significantly in both the groups at various stages as compared to preoperative values , the decrease being more but insignificant in group II. Changes in heart rate and mean blood pressure were similar and without statistically significant differences in either group at various stages of study. The amount of surgical blood loss in group I was 835.29 ± 684.37 ml, as compared to 865 + 409.78 ml in group II. The difference was statistically insignificant (p>0.05). The mean volume of homologous blood transfused in group I was 864.71 ± 349.89 ml, as compared to 165 ± 299.6 ml in group II which was statistically significant (p<0.05). In group II (ANH Group) only 5 patients (25%) required homologous blood whereas in group I I all patients (100%) needed homologous blood. Conclusion : We conclude that acute normovolemic hemodilution up to a target hematocrit of 30% is safe and effective in reducing the need for homologous blood in neurosurgical patients undergoing excision of intracranial meningioma.http://www.joacp.org/article.asp?issn=0970-9185;year=2011;volume=27;issue=1;spage=54;epage=58;aulast=NaqashSurgery: Neurosurgery; Transfusion: AutologousHomologous; Technique: Normovolemic hemodilution; Diluent: 6% hydroxyethyl starch
spellingShingle Imtiaz A Naqash
M A Draboo
Abdul Qayoom Lone
Showkat H Nengroo
Altaf Kirmani
Abdul Rashid Bhat
Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma
Journal of Anaesthesiology Clinical Pharmacology
Surgery: Neurosurgery; Transfusion: Autologous
Homologous; Technique: Normovolemic hemodilution; Diluent: 6% hydroxyethyl starch
title Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma
title_full Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma
title_fullStr Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma
title_full_unstemmed Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma
title_short Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma
title_sort evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma
topic Surgery: Neurosurgery; Transfusion: Autologous
Homologous; Technique: Normovolemic hemodilution; Diluent: 6% hydroxyethyl starch
url http://www.joacp.org/article.asp?issn=0970-9185;year=2011;volume=27;issue=1;spage=54;epage=58;aulast=Naqash
work_keys_str_mv AT imtiazanaqash evaluationofacutenormovolemichemodilutionandautotransfusioninneurosurgicalpatientsundergoingexcisionofintracranialmeningioma
AT madraboo evaluationofacutenormovolemichemodilutionandautotransfusioninneurosurgicalpatientsundergoingexcisionofintracranialmeningioma
AT abdulqayoomlone evaluationofacutenormovolemichemodilutionandautotransfusioninneurosurgicalpatientsundergoingexcisionofintracranialmeningioma
AT showkathnengroo evaluationofacutenormovolemichemodilutionandautotransfusioninneurosurgicalpatientsundergoingexcisionofintracranialmeningioma
AT altafkirmani evaluationofacutenormovolemichemodilutionandautotransfusioninneurosurgicalpatientsundergoingexcisionofintracranialmeningioma
AT abdulrashidbhat evaluationofacutenormovolemichemodilutionandautotransfusioninneurosurgicalpatientsundergoingexcisionofintracranialmeningioma